IRON
NASD Disc Medicine, Inc.$78.66 ↓ -0.82 (-1.03%) Trading Down from the previous close of $79.48, $1.34 below the day’s high of $80.00
- YTD change
- -0.94%
- vs 20-day SMA
- +24.38%
- vs 200-day SMA
- +11.32%
Price ranges
Price & Performance
+7.52 (+10.53%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 20.9% away from all-time highs of $99.50
- IRON is down 1% since the beginning of the year
- IRON is down 10% over the past 12 months
- IRON is up 15% over the past 1 month
- 22% of all IRON investors are betting against IRON
IRON reads very good: price sits above both the 20- and 200-day averages, the 12-month move is -9.5%.
- Previous minute
- +$0.00
- Last hour
- +$0.06
- Last 5 days
- +30.06%
- vs 8-day SMA
- +28.93%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
